Our patient had a genetic variation in complement factor H gene, which could be related to a dysregulation of the alternative pathway, and it could be hypothesized that he could have an immune-complex-mediated MPGN, although the negative immunofluorescence and the absence of this pattern in the subsequent biopsy are against this option. The gene discussed is CFH; the disease is primary membranoproliferative glomerulonephritis.